Cane Capital Partners’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
Other funds holding JNJ
Cane Capital Partners's JNJ Position: Q3 2026 in Review
Cane Capital Partners reduced its Johnson & Johnson (JNJ) stake by 8.2% in Q3 2026, selling an estimated $106K and leaving 4,477 shares worth $1.19M. The position accounts for 0.44% of the portfolio, ranked #53.
Cane Capital Partners first reported a position in JNJ in Q4 2025 and has held it in 4 quarters since. The position peaked at $1.38M in Q4 2025. 4,737 funds tracked by Wall St. Rank hold JNJ as of Q3 2026.
- Cane Capital Partners held 4,477 shares of Johnson & Johnson worth $1.19M as of Q3 2026.
- Cane Capital Partners sold 401 Johnson & Johnson shares in Q3 2026, an estimated $106K.
- Johnson & Johnson made up 0.44% of Cane Capital Partners's portfolio in Q3 2026, its #53 holding.
- Cane Capital Partners first reported a position in Johnson & Johnson in Q4 2025 and has held it in 4 quarters since.
- Cane Capital Partners's Johnson & Johnson position peaked at $1.38M in Q4 2025.
- 4,737 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2026.
Based on Cane Capital Partners's 13F filing for Q3 2026, filed 23 Oct 2026.